gms | German Medical Science

65. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

11. - 14. Mai 2014, Dresden

Implementation of intraoperative 3 Tesla MRI-guided intracerebral tumor resection in a two-room concept

Meeting Abstract

  • Oliver Bozinov - Klinik für Neurochirurgie, Universitätsspital Zürich, Zürich, Schweiz
  • Jan-Karl Burkhardt - Klinik für Neurochirurgie, Universitätsspital Zürich, Zürich, Schweiz
  • Marian C. Neidert - Klinik für Neurochirurgie, Universitätsspital Zürich, Zürich, Schweiz
  • Jorn Fierstra - Klinik für Neurochirurgie, Universitätsspital Zürich, Zürich, Schweiz
  • Luca Regli - Klinik für Neurochirurgie, Universitätsspital Zürich, Zürich, Schweiz

Deutsche Gesellschaft für Neurochirurgie. 65. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC). Dresden, 11.-14.05.2014. Düsseldorf: German Medical Science GMS Publishing House; 2014. DocDI.14.12

doi: 10.3205/14dgnc205, urn:nbn:de:0183-14dgnc2058

Veröffentlicht: 13. Mai 2014

© 2014 Bozinov et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Objective: Intraoperative 3 Tesla MRI (io3T MRI) has been implemented in our hospital with the rationale to increase tumor resection grade and correct for brain shift to thereby increase adequacy of surgery. However, implementing an io3T MRI system poses technical challenges, such as an inferior signal-to-noise quality due to the ioMRI head coil or intracranial air during an open surgical approach strategy. Also, a meticulous checklist has to be developed to assure patient safety, coordination between the interdisciplinary teams involved, and to achieve the highest image quality possible to make it comparable with a conventional cerebral 3T MRI examination.

Method: Observational study with enrollment of all patients that underwent an io3T MRI examination (Skyra, Siemens) during intracerebral tumor resection between 03/2013 to10/2013. We evaluated the implemented checklists, patient safety, adverse events, transfer and imaging time and image quality.

Results: A total of 35 patients including 20 gliomas (WHO Grade I n=3, II n= 3, III n= 9, and IV n= 6), 10 pituitary adenomas, 2 epidermoid cysts, 1 intracerebral metastasis and 1 PNET underwent io3TMRI examination during this period. In 33 patients (transcranial n=23 and transnasal n=10) intraoperative imaging was possible and safe without any reported adverse events. Tumor specific MRI sequences (T1 postcontrast, T2, FLAIR, diffusion weighted volumes) could be obtained in imaging quality comparable to a conventional 3T MRI examination. In 1 patient the transfer process was extended due to a technical problem of the docking procedure and in 1 small child the planned MRI scan needed to be canceled due to dislocation of the intubation tube during initial transfer.

Conclusions: Io3T MRI examination during intracerebral tumor resection was feasible and safe with an imaging quality comparable to that of a conventional 3T MRI examination in most patients. However, prone positioning in very small patients can be challenging in a transfer setting.